Sec. 4. Notice and certification of agreements
251 words·~1 min read·
/bill/113/s/214/is/section-4A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 1112(c)(2) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ( 21 U.S.C. 355 note) is amended by— striking the Commission the and inserting the following: “the Commission— the ; striking the period and inserting ; and ; and inserting at the end the following: any other agreement the parties enter into within 30 days of entering into an agreement covered by subsection
(a)or (b). . Section 1112 of such Act is amended by adding at the end the following: The Chief Executive Officer or the company official responsible for negotiating any agreement required to be filed under subsection (a), (b), or
(c)shall execute and file with the Assistant Attorney General and the Commission a certification as follows: I declare that the following is true, correct, and complete to the best of my knowledge: The materials filed with the Federal Trade Commission and the Department of Justice under section 1112 of subtitle B of title XI of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, with respect to the agreement referenced in this certification:
(1)represent the complete, final, and exclusive agreement between the parties;
(2)include any ancillary agreements that are contingent upon, provide a contingent condition for, or are otherwise related to, the referenced agreement; and
(3)include written descriptions of any oral agreements, representations, commitments, or promises between the parties that are responsive to subsection
(a)or
(b)of such section 1112 and have not been reduced to writing. . .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 4
Notice and certification of agreements
Cites 1Cited by 0 across 0 sources